News

Notice Regarding Additional Contributions Accompanying the Continuation of the Performance-Based Stock Compensation System

Notice regarding additional contributions related to the continuation of Trust-type Stock Delivery System for Employees

First Quarter Business Results for Fiscal Year 2025(Script with Q&A)

First Quarter Business Results for Fiscal Year 2025

Consolidated Financial Results for the First Quarter of the Term Ending March 31, 2026 (Under Japanese GAAP)

Supplementary Materials The First Quarter of the Term Ending March 31, 2026

Notice regarding the conclusion of an agreement for Tsumura China Inc. to acquire an interest in Shanghai Hongqiao Traditional Chinese Drug Pieces Co., Ltd.

Notice Concerning the Status and Conclusion of Share Repurchase

Notice of the 89th Ordinary General Meeting of Shareholders is now available

FY2024 Financial Resultsand Second Medium-Term Management Plan Briefing(script with Q&A)

FY2024 Financial Resultsand Second Medium-Term Management Plan Briefing(Presentation)

Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (Under Japanese GAAP)

2nd Medium-Term Management Plan (FY2025 - FY2027)

Supplementary Materials The Fiscal Year Ended March 31, 2025

Notice regarding the continuation of Trust-type Stock Delivery System for Employees

Notice regarding partial revision of the Performance-Based Stock Compensation System

Notice Concerning Status of Share Repurchases

Notice Concerning Status of Share Repurchases

Notice of Decision on Offer Price, etc.

(Progress of Disclosed Matters) Notice of Decision on Matters Relating to Purchase of Treasury Shares

Notice of Sale of Shares

Notice of Decision on Matters Relating to Purchase of Treasury Shares

Consolidated Financial Results for the Third Quarter of the Term Ending March 31, 2025 (Under Japanese GAAP) (Completion of Interim review by Certified Public Accountants, etc.)

Third Quarter Business Results for Fiscal Year 2024(Script with Q&A)

Third Quarter Business Results for Fiscal 2024

Consolidated Financial Results for the Third Quarter of the Term Ending March 31, 2025 (Under Japanese GAAP)

Supplementary Materials The Third Quarter of the Term Ending March 31, 2025

Tsumura Announces Revision of Earnings Forecast

Tsumura Announces Conclusion of Letter of Intent between Ping An Tsumura Inc. and Shanghai Hongqiao Pharmaceutical Co., Ltd.

Second Quarter(Interim Period)Business Results for Fiscal Year 2024(Script with Q&A)

Second Quarter(Interim Period) Business Results for Fiscal Year 2024

Consolidated Financial Results for the Six Months Ended March 31, 2025 (Under Japanese GAAP)

Supplementary Materials The Second Quarter(Interim Period)of the Term Ending March 31, 2025

First Quarter Business Results for Fiscal Year 2024(Script with Q&A)

First Quarter Business Results for Fiscal Year 2024

Consolidated Financial Results for the First Quarter of the Term Ending March 31, 2025 (Under Japanese GAAP)

Supplementary Materials The First Quarter of the Term Ending March 31, 2025

The 88th Ordinary General Meeting of Shareholders was held

Notice of the 88th Ordinary General Meeting of Shareholders is now available

Business Results for Fiscal Year 2023(Script with Q&A)

Business Results for Fiscal Year 2023(Presentation)

Consolidated Financial Results for the Fiscal Year Ended March 31, 2024(Under Japanese GAAP)

Supplementary Materials The Fiscal Year Ended March 31, 2024

Notice Concerning Dividends of Surplus (Dividend Increase)

Third Quarter Business Results for Fiscal Year 2023(Script with Q&A)

Third Quarter Business Results for Fiscal Year 2023(Presentation)

Consolidated Financial Results for the Third Quarter of the Term Ending March 31, 2024 (Under Japanese GAAP)

Supplementary Materials The Third Quarter of the Term Ending March 31, 2024

Notice Concerning Revision of Basic Capital Management Policy and Shareholder Return Policy and Revision of Dividends Projection (Dividend Increase)

Second Quarter Business Results for Fiscal Year 2023(Script with Q&A)

Second Quarter Business Results for Fiscal Year 2023(Presentation)

Consolidated Financial Results for the Second Quarter of the Term Ending March 31, 2024 (Under Japanese GAAP)

Supplementary Materials The Second Quarter of the Term Ending March 31, 2024

Tsumura Announces Revision of Earnings Forecast

First Quarter Business Results for Fiscal Year 2023(Conference Call)Q&A

First Quarter Business Results for Fiscal Year 2023(Conference Call with script)

First Quarter Business Results for Fiscal Year 2023(Conference Call)

Consolidated Financial Results for the First Quarter of the Term Ending March 31, 2024 (Under Japanese GAAP)

Supplementary Materials The First Quarter of the Term Ending March 31, 2024

The 87th Ordinary General Meeting of Shareholders was held

Notice of the 87th Ordinary General Meeting of Shareholders is now available

Business Results for Fiscal Year 2022 Q&A

Business Results for Fiscal Year 2022(with script)

Business Results for Fiscal Year 2022

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 31, 2023(Japan GAAP)

The Fiscal Year Ended March 31, 2023, Supplementary Materials

Tsumura Announces Conclusion of Agreement Regarding Acquisition of Equity Interest in Shaanxi Unisplendour Life Care Pharmaceutical Co., Ltd. by Ping An Tsumura Inc.

Tsumura Announces Introduction of Trust-type Stock Delivery System for Employees

TSUMURA USA, INC. Website has opened

Third Quarter Business Results for Fiscal Year 2022 Q&A

Third Quarter Business Results for Fiscal Year 2022(with script)

Third Quarter Business Results for Fiscal Year 2022

Consolidated Financial Results for the Third Quarter of the Term Ending March 31, 2023 (Under Japanese GAAP)

Supplementary Materials The Third Quarter of the Term Ending March 31, 2023

Second Quarter Business Results for Fiscal Year 2022 Q&A Summary

Second Quarter Business Results for Fiscal Year 2022(with script)

Second Quarter Business Results for Fiscal 2022

Notice Concerning Dividend from Surplus (Interim Dividend)

Consolidated Financial Results for the Second Quarter of the Term Ending March 31, 2023 (Under Japanese GAAP)

Supplementary Materials The Second Quarter of the Term Ending March 31, 2023

Tsumura Announces Signing of Letter of Intent Concerning Establishment of Joint Venture with Jianmin Pharmaceutical Group Co., Ltd.

Tsumura Announces Establishment of PINGAN TSUMURA TRADITIONAL CHINESE MEDICINE TECHNOLOGY CO., LTD.

First Quarter Business Results for Fiscal Year 2022(Conference Call)Q&A Summary

First Quarter Business Results for Fiscal Year 2022(Conference Call with script)

Tsumura Announces Revision of Earnings Forecast

Consolidated Financial Results for the First Quarter of the Term Ending March 31, 2023 (Under Japanese GAAP)

The Fiscal Year Ended March 31, 2023,Supplementary Materials

First Quarter Business Results for Fiscal Year 2022(Conference Call)

Tsumura Announces Completion of Payment for Disposition of Treasury Shares for Performance-Based Stock Compensation

Tsumura Announces Disposition of Treasury Shares for Performance-Based Stock Compensation

The 86th Ordinary General Meeting of Shareholders was held

Notice of the 86th Ordinary General Meeting of Shareholders

1st Medium-Term Management Plan (FY2022 - FY2024)

Business Results for FY 2021& New Medium-Term Management Plan Q&A Summary

Business Results for FY 2021& New Medium-Term Management Plan(with script)

Tsumura Announces Revision of Performance-Based Stock Compensation System

Notice Regarding Partial Amendment of the Articles of Incorporation

Business Results for FY 2021 & New Medium-Term Management Plan

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 31, 2022(Japan GAAP)

The Fiscal Year Ended March 31, 2022, Supplementary Materials

Sustainability Vision & Long-Term Management Vision Presentation(with note)

Sustainability Vision & Long-Term Management Vision Presentation(Q&A Summary)

Sustainability Vision & Long-Term Management Vision Presentation(with note)

Sustainability Vision & Long-Term Management Vision Presentation(Q&A Summary)

The Tsumura Group Sets Its Medium- to Long-Term Environmental Targets

Tsumura Human Rights Policy Established

Tsumura Procurement Policy Established

Sustainability content has been released

Sustainability Vision & Long-Term Management Vision Presentation

Sustainability Vision & Long-Term Management Vision Presentation

Third Quarter Business Results for Fiscal Year 2021(Conference Call)Q&A Summary

Third Quarter Business Results for Fiscal Year 2021(Conference Call with notes)

Third Quarter Business Results for Fiscal Year 2021(Conference Call)

Summary of Consolidated Financial Statements for the Third Quarter of the Term Ending March 31, 2022

Supplementary Materials

Second Quarter Business Results f or Fiscal Year 2021 Q&A Summary

Second Quarter Business Results for Fiscal Year 2021 Q&A Summary

Second Quarter Business Results for Fiscal Year 2021(with script)

Second Quarter Business Results for Fiscal 2021

Summary of Consolidated Financial Statements for the Second Quarter of the Term Ending March 31, 2022

Supplementary Materials

Announces Revision of Earnings Forecast

Announces Revision of Earnings Forecast

First Quarter Business Results for Fiscal Year 2021(Conference Call)Q&A Summary

First Quarter Business Results for Fiscal Year 2021(Conference Call)Q&A Summary

First Quarter Business Results for Fiscal Year 2021(Conference Call with script)

First Quarter Business Results for Fiscal Year 2021(Conference Call)

Consolidated Financial Results for the First Quarter of the Term Ending March 31, 2022

Supplementary Materials

The 85th Ordinary General Meeting of Shareholders

The 85th Ordinary General Meeting of Shareholders was held

Notice of the 85th Ordinary General Meeting of Shareholders

Business Results for Fiscal Year 2020 Q&A Summary

Business Results for Fiscal Year 2020 Q&A Summary

Business Results Briefing for the Fiscal Year 2020

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 31, 2021

Supplementary Materials

Third Quarter Business Results for Fiscal Year 2020(Conference Call)Q&A Summary

Third Quarter Business Results for Fiscal Year 2020(Conference Call)Q&A Summary

Third Quarter Business Results for Fiscal Year 2020(Conference Call with notes)

Third Quarter Business Results for Fiscal Year 2020(Conference Call)

Summary of Consolidated Financial Statements for the Third Quarter of the Term Ending March 31, 2021

Supplementary Materials

Second Quarter Business Results f or Fiscal Year 2020 Q&A Summary

Second Quarter Business Results f or Fiscal Year 2020 Q&A Summary

Second Quarter Business Results for Fiscal Year 2020(with notes)

Second Quarter Business Results for Fiscal 2020

Summary of Consolidated Financial Statements for the Second Quarter of the Term Ending March 31, 2021

Supplementary Materials

First Quarter Business Results for Fiscal Year 2020(Conference Call)Q&A Summary

First Quarter Business Results for Fiscal Year 2020(Conference Call)Q&A Summary

First Quarter Business Results for Fiscal Year 2020(Conference Call with notes)

First Quarter Business Results for Fiscal Year 2020(Conference Call)

Summary of Consolidated Financial Statements for the First Quarter of the Term Ending March 31, 2021

Supplementary Materials

The 84th Ordinary General Meeting of Shareholders

The 84th Ordinary General Meeting of Shareholders

Notice of the 84th Ordinary General Meeting of Shareholders

Business Results Briefing for the Fiscal Year 2019(with notes)

Business Results Briefing for the Fiscal Year 2019

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 31, 2020

Supplementary Materials

Tsumura Announces Conclusion of Agreement Regarding Acquisition of Equity Interest in Tianjin China Medico Technology CO., Ltd. by Ping An Tsumura Inc.

3Q Results Briefing (Conference Call) Summary text

3Q Results Briefing(conference call)

Summary of Consolidated Financial Statements for the Third Quarter of the Term Ending March 31, 2020

Supplementary Materials

Tsumura Announces Establishment of Capital Alliance with Tianjin China Medico Technology Co., Ltd. by Ping An Tsumura Inc.

Movie File : Financial results briefing for the Second Quarter of the Term Ending March 2020

Growth Investment in China & Building Business Foundations

Second Quarter Business Results for Fiscal 2019(From April 1, 2019 to September 30, 2019)

Tsumura Announces Establishment of Conclusion of Letter of Intent for Capital Alliance with Tianjin China Medico Technology Co., Ltd. by Ping An Tsumura Inc.

Summary of Consolidated Financial Statements for the Second Quarter of the Term Ending March 31, 2020

Supplementary Materials

Tsumura Announces Dissolution and Liquidation of its Joint Venture in China

Tsumura Announces Completion of Payment for Disposition of Treasury Shares for Performance-Based Stock Compensation

First Quarter Business Results for Fiscal 2019 (From April 1, 2019 to June 30, 2019)

Summary of Consolidated Financial Statements for the First Quarter of the Term Ending March 31, 2020

Supplementary Materials

Tsumura Announces Disposition of Treasury Shares for Performance-Based Stock Compensation

FY2018 Financial Results Briefing

Third Medium-Term Management Plan (Fiscal 2019 - Fiscal 2021)

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 31 2019

Supplementary Materials

Summary of Consolidated Financial Statements for the Third Quarter of the Term Ending March 31, 2019

Supplementary Materials

Movie File : Financial results briefing for the Second Quarter of the Term Ending March 2019

Financial results briefing for the Second Quarter of the Term Ending March 2019

Summary of Consolidated Quarterly Financial Statements for the Second Quarter of the Term Ending March 2019

The Second Quarter Term Ending March 2019 Supplementary Materials

Summary of Consolidated Quarterly Financial Statements for the First Quarter of the Term Ending March 2019

The First Quarter Term Ending March 2019 Supplementary Materials

Tsumura Announces Completion of Establishment of Joint Venture (Report of Progress)

Movie File: Financial results briefing for the FY 2017

FY2017 Financial Results Briefing

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 2018

Supplementary Materials

Capital and Business Alliance with MYFARM

Fiscal 2018 annual schedule

Movie File : Presentation on Vision for China Business

Tsumura to Hold Presentation on Vision for Business in China

Presentation on Vision for China Business

Summary of Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2018

Supplementary Materials

Oil Spill at Takikawa Farm (Takikawa City, Hokkaido)

Tsumura Announces Execution of Joint Venture Agreement with Ping An Insurance (Group) Company of China, Ltd.

Tsumura Announces Execution of Joint Venture Agreement with Tianjin China Medico Technology Co., Ltd.

Movie File : Financial results briefing for the Second Quarter of the Term Ending March 2018

Financial results briefing for the Second Quarter of the Term Ending March 2018

Summary of Consolidated Quarterly Financial Statements for the Second Quarter of the Term Ending March 2018

The Second Quarter Term Ending March 2018 Supplementary Materials

Notice of Completion of Payment for Issuing of New Shares and Disposal of Treasury Shares Through Third-Party Allotment

Tsumura Announces Capital and Business Alliance with Ping An Insurance (Group) Company of China, Ltd.,Issuance of New Shares and Disposal of Treasury Shares by Way of Third-Party Allotment,and Planned Change in Largest Shareholder Among Majo

Annual Report 2017

Summary of Consolidated Quarterly Financial Statements for the First Quarter of the Term Ending March 2018

Notice Regarding Issuance of Unsecured Bonds

Movie File: Financial results briefing for the FY 2016

FY2016 Financial Results Briefing

Notice Regarding Executive Appointments after Transition to Company with Audit and Supervisory Committee

Notice Regarding Partial Amendments to the Articles of Incorporation

Tsumura Announces Transition to Company with Audit and Supervisory Committee

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 2017

Fiscal 2017 annual schedule

Summary of Consolidated Quarterly Financial Statements for the Third Quarter of the Term Ending March 2017

Tsumura Announces Establishment of Tsumura China Inc.

Movie File : Financial results briefing for the Second Quarter of the Term Ending March 2017

Financial results briefing for the Second Quarter of the Term Ending March 2017

Summary of Consolidated Quarterly Financial Statements for the Second Quarter of the Term Ending March 2017

Notice Regarding Acquisition of Treasury Stock and Completion of Acquisition

Annual Report 2016

Notice Regarding Acquisition of Treasury Stock

Notice Regarding Acquisition of Treasury Stock

Tsumura Announces Decision on Matters Related to Acquisition of Treasury Stock

Summary of Consolidated Quarterly Financial Statements for the First Quarter of the Term Ending March 2017

Tsumura Announces Introduction of Performance-Linked Stock Compensation Plan

Movie File:Financial results briefing for Fiscal 2015 and New Medium-Term Management Plan

Tsumura Announces Change of Certified Public Accountant

Tsumura Announces Medium-Term Management Plan for FY 2016 to FY 2021

Tsumura Enters into a Business Collaboration Agreement with Tianjin China Medico Technology Co., Ltd. (China)

Tsumura Announces Establishment of a Joint Venture in China

Impact of the 2016 Earthquake in Kyusyu, Japan

The British journal Nature issues a press release on an experimental study on "TSUMURA Rikkunshito" Extract Granules for Ethical Use

Tsumura Announces Personnel Changes in Officers and Changes in Governance System

Tsumura Announces Full-scale Launch of its Farm Operations by Making Yubari Tsumura into an Agricultural Production Corporation

Tsumura Announces Inspection by Minister of Health, Labour and Welfare, Norihisa Tamura

Tsumura enters a Sponsorship Agreement for the "University of Oxford Innovative Systems Biology Project sponsored by Tsumura"

Regarding Support in Respect of Damage from Sichuan Earthquake

TSUMURA Announces Revised (Increased) Year-End Dividend Forecast for Term Ending March 2013

Tsumura Develops Medium-Term Management Plan for FY2012 to FY2015

TSUMURA Announces Partial Amendments to Articles of Incorporation

TSUMURA Announces Change in the Office of the President & Representative Director

LAO TSUMURA Recognized for Prospective Contribution to Laos

TSUMURA Announces Distribution of Dividends

Regarding the Resumption of Kampo Formulations Chief Plant Damaged by the Great East Japan Earthquake

Tsumura Establishes Technology for Cultivating Licorice Product of Joint Research with Chinese Groups and University

Recovering Condition of the Damage from "the 2011 Great East Japan Earthquake"

Impact from "the 2011 Great East Japan Earthquake"

Regarding the monetary donation, etc. from Chinese business partners. Tsumura & Co.

Regarding the Public Donation of Tsumura & Co. for "the 2011 off the Pacific coast of Tohoku Earthquake"

Tsumura Announces Increased Interim Dividends and Revised Year-End Dividend Forecast for Term Ending March 2011

Tsumura Revises Medium-Term Management Plan (Consolidated)

Tsumura Establishes a Local Corporation in Laos

Termination of Sales of Oral Contraceptive Agent, Synphase T28 Tablet

Tsumura Announces Increased Interim Dividends and Revised Year-End Dividend Forecast for Term Ending March 2010

Tsumura Establishes a Subsidiary for Botanicals Business in Hokkaido

Tsumura Provides Three OTC Kampo Formulations to Takeda Pharmaceutical Company Limited.

Notice of Abolition of Shareholder Special Benefit Plan

Tsumura Announces Medium-Term Management Plan for FY 2009 to FY 2011(Consolidated)

Tsumura Establishes Production, Processing and Storage Facility for Raw Medicinal Herbs in Yubari City, Hokkaido

About the transfer of approval to production and marketing of ASTAT®, an external-use, anti-fungal drug for ethical use

Tsumura Revises Earning Forecast

Tsumura Revises Dividend Forecast for Fiscal Year Ending March 2009 (73rd Term)

Transfer of Shares in Tsumura Lifescience Co., Ltd.

Tsumura Revises Year-End Dividend Forecast (Dividend Increase) for Fiscal Year Ending March 2008 (72nd Term)

Notice Regarding Transfer of Shares in Overseas Subsidiary

Tsumura to Discontinue Development of TU-025 (Keishibukuryogan) in the U.S.

Tsumura Announces Medium-Term Management Plan for FY 2007 to FY 2009 (Consolidated)

Notice of Partial Change of Shareholder Special Benefit Plan

Notice of Change in Number of Shares per Stock Trading Unit

Announcement on the Development of TU-025 (Keishibukuryogan) in the U.S.